(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARETÉ STRATEGIES BIO-PHARMA ADVISORS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ARETÉ STRATEGIES BIO-PHARMA ADVISORS

ST13

US500000085619846

Class

35

Filing

85619846

Registration

4768986

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

60

Latest update

08/22/2025

Trademark type

Combined

Nice classes

35

Filing date

05/08/2012

Registration date

07/07/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/21/2025

Last transaction

08/22/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/31/2011

First use in commerce

08/31/2011

Drawing code

3

Owner type

01

Owner location

Palo Alto, CA

Examiner

CARLSON, KRISTIN

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "ARETÉ" appearing in bold and above the word "STRATEGIES" in all capital letters which is above the phrase "BIO-PHARMA ADVISORS". All the wording is centered between six curved bands, three stacked to the left of the wording and three stacked to the right of the wording.

Holders and representatives

Holders

A. J. (pessoa física)
A. J. (pessoa física)

Representatives

Paul E. Thomas Pillsbury Winthrop Shaw Pittman LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting servicesproduct and service commercialization services for pharmaceuticalbiotechnologydiagnostic technologymedical devicevaccine productionlife sciences technology customers in the field of health care products and services

Publications

History of USPTO decisions and trademark events.

60 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/21/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/21/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/21/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/21/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

04/10/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/07/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/30/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/30/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/30/2021

E815

TEAS SECTION 8 & 15 RECEIVED

06/18/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/07/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/14/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

07/07/2015

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/03/2015

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/02/2015

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/28/2015

IUAF

USE AMENDMENT FILED

05/11/2015

EISU

TEAS STATEMENT OF USE RECEIVED

05/11/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/11/2014

EX2G

SOU EXTENSION 2 GRANTED

12/10/2014

NREV

NOTICE OF REVIVAL - E-MAILED

12/09/2014

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

12/08/2014

PETG

PETITION TO REVIVE-GRANTED

12/08/2014

PROA

TEAS PETITION TO REVIVE RECEIVED

12/08/2014

EXT2

SOU EXTENSION 2 FILED

11/08/2014

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/29/2014

EX1G

SOU EXTENSION 1 GRANTED

05/28/2014

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/23/2014

EXT1

SOU EXTENSION 1 FILED

05/01/2014

EEXT

SOU TEAS EXTENSION RECEIVED

05/01/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/12/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/17/2013

PUBO

PUBLISHED FOR OPPOSITION

09/17/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/28/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/13/2013

ALIE

ASSIGNED TO LIE

08/08/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/26/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/25/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/24/2013

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

07/24/2013

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/29/2013

GNSL

LETTER OF SUSPENSION E-MAILED

05/29/2013

CNSL

SUSPENSION LETTER WRITTEN

05/29/2013

DOCK

ASSIGNED TO EXAMINER

05/29/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/01/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/30/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/30/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/01/2012

GNRT

NON-FINAL ACTION E-MAILED

11/01/2012

CNRT

NON-FINAL ACTION WRITTEN

11/01/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/28/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/27/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/27/2012

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/07/2012

GNRT

NON-FINAL ACTION E-MAILED

09/07/2012

CNRT

NON-FINAL ACTION WRITTEN

09/07/2012

DOCK

ASSIGNED TO EXAMINER

08/28/2012

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

05/16/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/15/2012

NWAP

NEW APPLICATION ENTERED

05/11/2012

Continuous trademark protection

Get notified about every new filing that threatens ARETÉ STRATEGIES BIO-PHARMA ADVISORS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.